China NMPA Product Recall - Activation solution

On May 28, 2021, the National Medical Products Administration (NMPA) publicly reported a Class III voluntary recall initiated by Abbott Ireland Diagnostics Division. This recall pertains to specific models and batches of the ARCHITECT TRIGGER SOLUTION, which operates under Recordation No. 20150075. The recall was prompted by Abbott Trading (Shanghai) Co., Ltd., identifying a significant labeling issue on the affected products. As a result, the manufacturer, Abbott Ireland Diagnostics Division, proactively undertook this recall to ensure compliance and patient safety. The Class III designation indicates that the product issue, while requiring correction, is unlikely to cause serious adverse health consequences. This action highlights the robust regulatory framework of the NMPA in overseeing medical device quality and safety within China. Companies like Abbott are required to promptly report and address such discrepancies, with detailed information about the affected product models, specifications, and batch numbers available in the official "Medical Device Recall Event Report Form." This voluntary recall demonstrates the manufacturer's commitment to maintaining product integrity and adhering to stringent regulatory standards.